Evidence map›Paper›PMID 18471903›Full record

ReviewTrends in neurosciences2008

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Susan A Masino, Jonathan D Geiger

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Adenosine and Ketogenic Treatments.Journal of caffeine and adenosine research · 2020
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ketone-Based Metabolic Therapy: Is Increased NADFrontiers in molecular neuroscience · 2017
    Article
  19. Review
  20. Adenosinergic signaling in epilepsy.Neuropharmacology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Susan A MasinoNeuroscience Program/Psychology Department, Trinity College, Life Sciences Center, 300 Summit Street, Hartford, CT 06106, USA. susan.masino@trincoll.edu
Jonathan D Geiger
College Summit · USUniversity of North Dakota · US

Funding

TRPC1, CALCIUM AND PARKINSON'S DISEASEP20RR017699 · NCRR · UNIVERSITY OF NORTH DAKOTA · PI GHRIBI, OTHMAN · 2002 to 2011
$19.7M
ADENOSINE AND MODULATION OF SYNAPTIC TRANSMISSIONR01NS029173 · NINDS · UNIVERSITY OF COLORADO DENVER · PI MASINO, SUSAN A · 1991 to 2004
$1.2M
The modulation of adenosine by temperature, oxygen and glucoseR15NS061290 · NINDS · TRINITY COLLEGE · PI MASINO, SUSAN A · 2008 to 2008
$261k
Howard Hughes Medical InstituteNCRR NIH HHS P20 RR017699NCRR NIH HHS RR017699NINDS NIH HHS NS29173NINDS NIH HHS NS61290NINDS NIH HHS R01 NS029173NINDS NIH HHS R15 NS061290
6 · The paper itself

Abstract

Abnormal neuronal signaling caused by metabolic changes characterizes several neurological disorders, and in some instances metabolic interventions provide therapeutic benefits. Indeed, altering metabolism either by fasting or by maintaining a low-carbohydrate (ketogenic) diet might reduce epileptic seizures and offer neuroprotection in part because the diet increases mitochondrial biogenesis and brain energy levels. Here we focus on a novel hypothesis that a ketogenic diet-induced change in energy metabolism increases levels of ATP and adenosine, purines that are critically involved in neuron-glia interactions, neuromodulation and synaptic plasticity. Enhancing brain bioenergetics (ATP) and increasing levels of adenosine, an endogenous anticonvulsant and neuroprotective molecule, might help with understanding and treating a variety of neurological disorders.

Indexed as

Diet, Carbohydrate-RestrictedAnimalsBrain DiseasesHumansNeuroprotective AgentsPurinesNeuroprotective AgentsPurines

Identifiers

PMID18471903
PMCPMC4469341
OpenAlexW2049045958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.